8-KThe WireStrategic
New Debt / Obligation
Filed Sep 24, 2024 · 1y ago · Accession 0001193125-24-224801
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- UroGen Pharma Ltd.
- Ticker
- URGN
- CIK
- 1668243
- Form type
- 8-K
- Filing date
- Sep 24, 2024
- Report date
- Sep 23, 2024
- Document
- d849854d8k.htm
- Size
- 145 KB